Aemetis (AMTX)
(Delayed Data from NSDQ)
$3.00 USD
0.00 (0.00%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $2.99 -0.01 (-0.33%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.00 USD
0.00 (0.00%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $2.99 -0.01 (-0.33%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth F Momentum B VGM
Zacks News
Aemetis (AMTX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -13.79% and 11.69%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Aemetis (AMTX) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -34.88% and 7.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Should Constellation (CEG) Be in Your Portfolio Before Q1 Earnings?
by Zacks Equity Research
Constellation Energy's (CEG) first-quarter earnings are likely to have gained from strong demand from its C&I customers.
Aemetis (AMTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Aemetis (AMTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aemetis (AMTX) Soars 39.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Aemetis (AMTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Sunrun (RUN) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Sunrun's (RUN) Q4 results are likely to reflect the impact of a decline in its year-over-year solar energy capacity installed in California and higher interest expenses.
SolarEdge (SEDG) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
SolarEdge's (SEDG) Q4 results are likely to reflect the negative impacts of slow market demand and higher operating expenses.
Exxon Mobil (XOM) Q3 Earnings Lag Estimates
by Zacks Equity Research
Exxon (XOM) delivered earnings and revenue surprises of -3.81% and 1.65%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Aemetis (AMTX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -142.86% and 32.97%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for July 27th
by Zacks Equity Research
AMTX, AROW and BHP have been added to the Zacks Rank #5 (Strong Sell) List on July 27, 2023.
New Strong Sell Stocks for July 21th
by Zacks Equity Research
AMTX, BHB and BNL have been added to the Zacks Rank #5 (Strong Sell) List on July 21, 2023.
New Strong Sell Stocks for July 18th
by Zacks Equity Research
AMTX, AU and BP have been added to the Zacks Rank #5 (Strong Sell) List on July 18, 2023.
Aemetis (AMTX) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -151.72% and 96.31%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Aemetis (AMTX) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -85.29% and 10.81%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Earthstone Energy (ESTE) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Earthstone Energy (ESTE) delivered earnings and revenue surprises of 9.47% and 1.81%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Aemetis (AMTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Aemetis (AMTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Fortress Energy (NFE) Q4 Earnings Beat Estimates
by Zacks Equity Research
New Fortress Energy (NFE) delivered earnings and revenue surprises of 19.18% and 31.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for First Solar (FSLR) in Q4 Earnings?
by Zacks Equity Research
First Solar's (FSLR) Q4 results are likely to reflect the strong demand for products and solid bookings, along with the negative impact of higher costs on earnings.
Occidental Petroleum (OXY) to Post Q4 Earnings: What to Expect
by Zacks Equity Research
Occidental's (OXY) fourth-quarter earnings are likely to have gained from strong production from the Gulf of Mexico and Rockies region. Share repurchases and debt reduction would also boost earnings.
Sunrun (RUN) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Sunrun's (RUN) Q4 results are likely to reflect a strong top line, buoyed by strength in the installation volume and a growing customer base.
Aemetis (AMTX) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of -15% and 9%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
How Much Upside is Left in Aemetis (AMTX)? Wall Street Analysts Think 210%
by Zacks Equity Research
The mean of analysts' price targets for Aemetis (AMTX) points to a 210% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Beat the Market the Zacks Way: Walt Disney (DIS), AmerisourceBergen (ABC), C.H. Robinson Worldwide (CHRW) in Focus
by Tirthankar Chakraborty
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week.
Does Aemetis (AMTX) Have the Potential to Rally 149% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 149.1% in Aemetis (AMTX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Aemetis (AMTX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Aemetis (AMTX) delivered earnings and revenue surprises of 88.89% and 6.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?